Shopping Cart
Remove All
Your shopping cart is currently empty
MTX-216 is an ATP-competitive inhibitor targeting both PI3K and EGFR. It simultaneously inhibits Ki-67 and ribosomal S6 phosphorylation, inducing apoptosis in NF1LOF cells. Additionally, MTX-216 suppresses SYK kinase activity with an IC50 of 281 nM. This compound is applicable for melanoma research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | MTX-216 is an ATP-competitive inhibitor targeting both PI3K and EGFR. It simultaneously inhibits Ki-67 and ribosomal S6 phosphorylation, inducing apoptosis in NF1LOF cells. Additionally, MTX-216 suppresses SYK kinase activity with an IC50 of 281 nM. This compound is applicable for melanoma research. |
| In vitro | MTX-216 exhibits strong inhibitory effects on the growth of NF1 LOF melanoma both in vitro and in vivo. Additionally, MTX-216 suppresses the expression of a group of genes that regulate the mitochondrial electron transport chain. |
| In vivo | MTX-216 (50 mg/kg, administered every other day from days 11 to 20, in mice transplanted with COLO792 and WM3918 cells) inhibits tumor growth. |
| Molecular Weight | 502.348 |
| Formula | C22H14Cl2FN5O2S |
| Cas No. | 1952236-19-9 |
| Smiles | N#CC=1C=NC2=CC=C(C=C2C1NC3=CC=C(F)C(Cl)=C3)C=4C=NC(Cl)=C(C4)NS(=O)(=O)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.